Charles Hsu
Direttore/Membro del Consiglio presso Optivia Biotechnology, Inc.
Provenienza dei contatti di primo grado di Charles Hsu
Entità | Tipo di entità | Settore Industriale | |
---|---|---|---|
Pappas Capital LLC
Pappas Capital LLC Investment ManagersFinance Pappas Capital LLC (Pappas Ventures) is a venture capital firm founded in 1994 by Art M. Pappas. The firm is headquartered in Durham, North Carolina.
12
| Private Company | Investment Managers | 12 |
Optivia Biotechnology, Inc.
Optivia Biotechnology, Inc. Pharmaceuticals: MajorHealth Technology Optivia Biotechnology, Inc. provides contract research organization offering drug transporter research services and solutions to biotechnology, pharmaceutical and academic organizations. It offers regulatory DDI studies, transporter screening, tranporter profiling, and custom development services. The firm's products include TransFlex Single Transporter Assay Plates,TransFlex Multi-Transporter Model Plates, and Certified Efflux Transporter Vesicles. The company was founded by Yong Huang, Pascal Druzgala and Peter G. Milner in 2007 and is headquartered in Santa Clara, CA.
5
| Subsidiary | Pharmaceuticals: Major | 5 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Charles Hsu tramite i suoi contatti personali
Società | Settore | Persone collegate | Posizione principale |
---|---|---|---|
Washington University in St. Louis | College/University | Corporate Officer/Principal | |
WINDTREE THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman | |
CHIMERIX, INC. | Pharmaceuticals: Major | Public Communications Contact | |
Santarus, Inc.
Santarus, Inc. Pharmaceuticals: MajorHealth Technology Santarus, Inc. operates as a biopharmaceutical company. The company was founded on December 6, 1996 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Silverback Asset Management LLC
Silverback Asset Management LLC Investment ManagersFinance Silverback Asset Management LLC (Silverback) is an independent, SEC-registered investment advisor and hedge fund manager headquartered in Chapel Hill, North Carolina. The firm was founded by Elliot Bossen in 2002. Silverback offers investment solutions for qualified institutional investors which includes pension funds, endowments, insurance companies, fund of funds, family offices and others. | Investment Managers | Analyst-Equity | |
TRILLIUM THERAPEUTICS | Biotechnology | Director/Board Member | |
CHELSEA THERAPEUTICS INTERNATIONAL LTD. | Biotechnology | Chief Executive Officer | |
Rotation Medical, Inc.
Rotation Medical, Inc. Medical SpecialtiesHealth Technology Rotation Medical, Inc. develops treatment of rotator cuff disease. It includes a bioinductive implant and a set of disposable arthroscopic instruments that has been shown to heal tendons by inducing the growth of new tendon-like tissue. The company was founded by Thomas R. Hektner in 2009 and is headquartered in Plymouth, MN. | Medical Specialties | Director/Board Member | |
Galleon Pharmaceuticals, Inc.
Galleon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Galleon Pharmaceuticals, Inc. develops and manufactures medicines for breathing-control conditions. Its product pipeline addresses the needs of both acute and chronic care patients. The firm's GAL-021 product is a small molecule for intravenous administration designed to support respiratory drive in surgical and critical care patients, and in particular those high risk patients with sleep apnea who are undergoing surgery. The company was founded by James C. Mannion in 2003 and is headquartered in Horsham, PA. | Pharmaceuticals: Major | Chief Executive Officer | |
MILESTONE PHARMACEUTICALS INC. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
Duke University
Duke University Other Consumer ServicesConsumer Services Duke University is an academic university that offers undergraduate, graduate and professional programs. It also has publications and research services. The university was founded in 1838 and is headquartered in Durham, NC. | College/University | Doctorate Degree Masters Business Admin | |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal | |
The University of Liverpool
The University of Liverpool Other Consumer ServicesConsumer Services The University of Liverpool operates as a university. It offers post graduate research, foundation courses, continuing and professional development, online study, and doctoral college. The company was founded in 1881 and is headquartered in Liverpool, the United Kingdom. | College/University | Doctorate Degree | |
Xenon Vision, Inc.
Xenon Vision, Inc. Miscellaneous Commercial ServicesCommercial Services Part of W World Corp., Xenon Vision, Inc. is a vision research concern. The company is based in Alachua, FL. Xenon Vision was acquired by Pharmatec, Inc. on November 03, 1992. | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer | |
ARYX THERAPEUTICS, INC. | Pharmaceuticals: Major | Corporate Officer/Principal Founder Founder | |
Rutgers State University of New Jersey | College/University | Masters Business Admin | |
University of Florida | College/University | Doctorate Degree | |
Université de Montpellier | College/University | Doctorate Degree | |
ABV LLC
ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Investment Managers | Corporate Officer/Principal | |
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
Gentis, Inc.
Gentis, Inc. Medical SpecialtiesHealth Technology Gentis, Inc. engages in the development and testing technologies for the minimally invasive treatments. The company was founded by Charles Cohen and Paul Ducheyne in 2000 and is headquartered in Wayne, PA. | Medical Specialties | Director/Board Member Director/Board Member | |
Lifeline Technologies, Inc.
Lifeline Technologies, Inc. BiotechnologyHealth Technology Lifeline Technologies, Inc. operates as a health sciences development company which focuses on novel strategies. It offers ChoLESStolife, a non-prescription and non-synthetic cholesterol absorption inhibitor for the reduction of human cholesterol using a fat-free delivery system for soy sterols and stanols. The company was registered by Curtis A. Spilburg and Richard E. Ostlund on October 1, 2002 and is headquartered in Hendersonville, NC. | Biotechnology | Director/Board Member | |
Ischemix, Inc.
Ischemix, Inc. Pharmaceuticals: MajorHealth Technology Ischemix, Inc. is a privately-held drug development company based in an undisclosed location. The American company focuses on developing its family of cytoprotective compounds for serious diseases and conditions, with the primary focus being the development of its lead compound, CMX-2043, for the treatment of TBI. Ischemix is working to advance cytoprotective therapies. The company was founded in 1999 by Victor Shashoua, and David DeWahl has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
Advanced Therapies, Inc. | Founder | ||
UNC Kenan-Flagler Private Equity Fund
UNC Kenan-Flagler Private Equity Fund Investment ManagersFinance UNC Kenan-Flagler Private Equity Fund (UNC Kenan-Flagler) is a private equity subsidiary of KFBSF, Inc. founded in 2007 by Greg Brown. The firm is headquartered in Chapel Hill, North Carolina. | Investment Managers | Chief Investment Officer | |
Retrotope, Inc.
Retrotope, Inc. Pharmaceuticals: MajorHealth Technology Retrotope, Inc. operates as clinical-stage pharmaceutical company that develops drugs to treat degenerative diseases. It offers drugs and therapies to treat Parkinson’s, Alzheimer’s, mitochondrial myopathies and retinopathies diseases. The company was founded by Charles R. Cantor, Robert J. Molinari, and Mikhail S. Shchepinov in 2006 and is headquartered in Los Altos, CA. | Pharmaceuticals: Major | Director/Board Member | |
Kenan-Flagler Business School | College/University | Masters Business Admin | |
SinuSys Corp.
SinuSys Corp. Medical SpecialtiesHealth Technology SinuSys Corp. develops medical device therapies to improve the sinus health of patients with chronic sinusitis. Its products include Vent-OS sinus dilation system, Restora steroid-eluting spacer, and SinuSys product pipeline. The company was founded by Jerome Hester and Thomas A. Schreck in 2010 and is headquartered in Palo Alto, CA. | Medical Specialties | Director/Board Member | |
The University of North Carolina at Charlotte | College/University | Undergraduate Degree | |
NYU Langone Health
NYU Langone Health Packaged SoftwareTechnology Services NYU Elaine A. & Kenneth G. Langone Medical Center provides health care services. It offers treatments for bone, joint, and muscle disorders; brain and nervous system disorders cancers, tumors and blood disorders; genetic and chromosomal disorders and immune system disorders. The company was founded in 1841 and is headquartered in New York, NY. | Packaged Software | Director/Board Member | |
AshHill Investments LLC
AshHill Investments LLC Investment ManagersFinance AshHill Investments LLC (AshHill Investments) is a venture capital firm founded in 2011. The firm is headquartered in Ft. Thomas, Kentucky. | Investment Managers | Chief Executive Officer | |
Armetheon, Inc.
Armetheon, Inc. Pharmaceuticals: MajorHealth Technology Armetheon, Inc. engages in medical development. It specializes in thrombosis and cardiac arrhythmias. The company was founded by Pascal J. Druzgala, Muralitharan Ken Kengatharan and Peter G. Milner in 2011 and is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Founder Founder | |
NEURONAX SA
NEURONAX SA Pharmaceuticals: MajorHealth Technology NEURONAX SA develops and provides drugs supporting neural repair to treat degenerative disorders of the central nervous system. Its services include cell culture, in vitro evaluation, neurotrophic and neuroprotective effects analysis, culture analyses, and stem cells. The company was founded by Stéphane Gobron, Fabrice Cailloux, and Pierre-Yves Simonin in 2003 and is headquartered in Saint-Beauzire, France. | Pharmaceuticals: Major | Director/Board Member | |
NYU Innovation Venture Fund
NYU Innovation Venture Fund Investment ManagersFinance NYU Innovation Venture Fund, seeks investment opportunities in companies located in the United States. The fund targets start-up companies operating in the fields of information technology, computer software and biotechnology, especially by current NYU students, faculty, and researchers. It provides equity financing for seed capital requirements with an investment size ranging from USD 100,000 to 1 million. The fund does not invest in projects requiring further basic research. | Investment Managers | Director/Board Member | |
NobleHealth, Inc.
NobleHealth, Inc. Financial ConglomeratesFinance Mosaic Health Solutions, Inc. provides financial investments in the field of healthcare. It is developing an integrated suite of market-leading solutions to accelerate health innovation and through strategic investments, partnerships and the creation of new companies, the firm is making health care better by empowering consumers and enabling healthier living. The company was incorporated on June 28, 2007 and is headquartered in Durham, NC. | Financial Conglomerates | Corporate Officer/Principal | |
Milestone Pharmaceuticals USA, Inc.
Milestone Pharmaceuticals USA, Inc. Pharmaceuticals: MajorHealth Technology Part of Milestone Pharmaceuticals, Inc., Milestone Pharmaceuticals USA, Inc. develops cardiovascular drugs. The company is based in Charlotte, NC. Joseph G. Oliveto has been the CEO of the company since 2017. | Pharmaceuticals: Major | Chief Executive Officer | |
Concarlo Holdings LLC
Concarlo Holdings LLC Miscellaneous Commercial ServicesCommercial Services Concarlo Holdings LLC operates as a biotechnology firm. It specializes in drug development. The company was founded by Stacy Blain and LisaMarie Casey and is headquartered in Brooklyn, NY. | Miscellaneous Commercial Services | Chairman | |
Majalin LLC
Majalin LLC Investment ManagersFinance Majalin LLC (Majalin), doing business as Amzak Health, is a private equity and venture capital subsidiary of Amzak Capital Management LLC, ultimately owned by Amzak International, Inc. The firm was founded in 2015 by Joyce Erony and is headquartered in New York, NY. | Investment Managers | Private Equity Investor | |
Delphinus Therapeutics, Inc. | Chief Executive Officer | ||
Renexxion LLC
Renexxion LLC Pharmaceuticals: MajorHealth Technology Renexxion LLC is a gastrointestinal biopharmaceutical company. It develops naronapride. The company was founded by Peter G. Milner, Muralitharan Kengatharan , and Pascal J. Druzgala in 2014 and is headquartered in Menlo Park, CA. | Pharmaceuticals: Major | Founder Founder | |
Sibylla Biotech Srl
Sibylla Biotech Srl Internet Software/ServicesTechnology Services Sibylla Biotech Srl engages in research and development activities in the pharmaceutical sector. It specializes in studies through its proprietary atom computer simulations for new drug discoveries. The company was founded by Maria Letizia Barreca and Emiliano Biasini in 2017 and is headquartered in Trento, Italy. | Internet Software/Services | Chairman | |
Université Paris-Saclay | College/University | Doctorate Degree | |
Diaccurate SA
Diaccurate SA Medical SpecialtiesHealth Technology Diaccurate SASU engages in the research of diagnostic products. It offers diagnostic products especially in the field of theranostics. The firm operates as a biopharmaceutical company that engages in developing new therapies for the treatment of HIV infection. The company was founded in 2012 and is headquartered in Paris, France. | Medical Specialties | Chief Tech/Sci/R&D Officer |
Statistiche
Distribuzione geografica
Stati Uniti | 39 |
Francia | 5 |
Canada | 3 |
Regno Unito | 3 |
Irlanda | 2 |
Settori
Health Technology | 25 |
Consumer Services | 10 |
Finance | 9 |
Commercial Services | 5 |
Technology Services | 3 |
Posizioni
Director/Board Member | 44 |
Corporate Officer/Principal | 19 |
Chief Executive Officer | 16 |
Founder | 15 |
President | 12 |
Contatti più connessi
Insiders | |
---|---|
Arthur Klausner | 18 |
Peter G. Milner | 18 |
W. Amick | 13 |
Scott E. Weiner | 9 |
Pascal J. Druzgala | 9 |
Joseph Oliveto | 7 |
Elizabeth Kelly | 7 |
Dominique Bridon | 7 |
Geoffrey R. Erickson | 6 |
Karen J. Martell | 5 |
Doreen M. Grech | 5 |
Jing You | 1 |
Emily C. Sheets | 1 |
Francis J. Meyer | 1 |
C. Robert Hallford | 1 |
- Borsa valori
- Insiders
- Charles Hsu
- Connessioni Società